Because so many people suffer from the symptoms of fibromyalgia, pharmaceutical companies are working very hard to develop medications that are specifically effective for people with fibromyalgia. As a result, new and better treatments should be available within the next few years or even sooner. So hang on, if you're dissatisfied with the medications that are available now. Help is on its way.
As of this writing, research appears to be surging ahead in such areas as growth hormones or dopamine receptor agonists. Some researchers have already shown that growth hormone or dopamine receptor agonists have improved the symptoms of some patients with fibromyalgia; further study is needed, however. The key problem with growth hormone is that this particular therapy is very expensive, and until the price comes down further, it can't be widely used as a therapy for fibromyalgia patients.
Researchers are also working on the development of medications that are a triple threat to FMS pain, inhibiting the reuptake of serotonin, norepinephrine, and dopamine. So far, these drugs have not been approved by the FDA and, thus, are not available to the public, but look for this type of medication in the future.
I really can't say exactly when drugs that are currently in the pipeline (that is, in clinical testing) as of this writing will actually receive FDA approval and become available to fibromyalgia patients down the road. Medications can't be prescribed for patients until they've been both thoroughly tested in clinical trials and approved by the FDA to be sold to patients in the United States. But probably within the next two to five years, FMS sufferers will have many new choices to treat the pain, fatigue, and other symptoms of fibromyalgia.
Was this article helpful?